Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors for and Repair of Obstetric Anal Sphincter Injuries.

Obstetrics and gynecology·2026
Same author

Three-Year Outcomes of Second-Stage Pushing Timing on Postpartum Pelvic Floor Morbidity.

Obstetrics and gynecology·2025
Same author

Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura.

Blood·2025
Same author

Spatiotemporal reconstruction of the North American A(H5N1) outbreak reveals successive lineage replacements by descendant reassortants.

Science advances·2025
Same author

Initiation and Utilization of Psychotherapy in Women With Overactive Bladder.

Urogynecology (Philadelphia, Pa.)·2025
Same author

Pelvic Floor Health Knowledge With Enhanced Education During Pregnancy.

Urogynecology (Philadelphia, Pa.)·2025
Same journal

Global Landscape and Translational Trajectories of Pelvic Floor Muscle Rehabilitation for Urinary Incontinence.

International urogynecology journal·2026
Same journal

Acquired Complete Obliteration of the Vaginal Canal-Surgical Techniques for Management.

International urogynecology journal·2026
Same journal

Factors Associated with Urinary Incontinence During Pregnancy: Clinical, Obstetric, and Metabolic Analysis.

International urogynecology journal·2026
Same journal

Comment on "TECAR Therapy in Pelvic Floor Rehabilitation for Women with Pelvic Pain: A Case-Control Study".

International urogynecology journal·2026
Same journal

Pharmacological Management of Stress Urinary Incontinence with Atypical Leakage Features, Symptom Response to Short-Term Solifenacin Trial.

International urogynecology journal·2026
Same journal

Sacral Neuromodulation Test-Phase Success in Bladder Pain Syndrome: Systematic Review and Meta-Analysis.

International urogynecology journal·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Levator myalgia: why bother?

Kerrie Adams1, W Thomas Gregory, Blake Osmundsen

  • 1Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR, Mail Code L466, 97239, USA, adamske@ohsu.edu.

International Urogynecology Journal
|April 12, 2013
PubMed
Summary
This summary is machine-generated.

Levator myalgia (LM) is common in urogynecology patients, affecting younger women and causing significant symptom bother. This condition is linked to higher rates of fibromyalgia, depression, and pain medication use.

More Related Videos

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
07:49

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes

Published on: September 20, 2019

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Related Experiment Videos

Last Updated: May 12, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
07:49

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes

Published on: September 20, 2019

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

Area of Science:

  • Urogynecology
  • Pelvic Floor Disorders
  • Pain Management

Background:

  • Levator myalgia (LM) is an examination finding in urogynecology.
  • Understanding its prevalence and associated factors is crucial for patient care.

Purpose of the Study:

  • To determine the prevalence of levator myalgia (LM) in a urogynecology referral population.
  • To describe symptom bother and comorbidities associated with LM.

Main Methods:

  • A cross-sectional study was conducted in private and university-based urogynecology practices.
  • Patients with and without LM were compared regarding demographics, symptom scores (PFDI, PFIQ), and comorbidities.

Main Results:

  • LM prevalence was 24% in the university setting and 9% in private practice.
  • Patients with LM were younger and reported significantly higher symptom bother for prolapse, urinary, and defecatory issues.
  • LM was associated with higher rates of fibromyalgia, depression, sexual abuse history, and narcotic pain medication use.

Conclusions:

  • Levator myalgia is a prevalent condition encountered in urogynecology.
  • LM is associated with increased symptom bother and a higher likelihood of specific comorbidities.